Cargando…

Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors

Metastatic prostate cancer is initially sensitive to androgen receptor inhibition, but eventually becomes castration-resistant prostate cancer (mCRPC). Early use of more intensive therapies targeting androgen receptor and other oncogenic drivers in treatment-naïve primary prostate cancer (PC) may be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Einstein, David J., Arai, Seiji, Calagua, Carla, Xie, Fang, Voznesensky, Olga, Capaldo, Brian J., Luffman, Christina, Hecht, Jonathan L., Balk, Steven P., Sowalsky, Adam G., Russo, Joshua W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2021
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457789/ https://www.ncbi.nlm.nih.gov/pubmed/34568716 http://dx.doi.org/10.1200/PO.21.00059

Ejemplares similares

Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance
por: Huang, Phoebe A., et al.
Publicado: (2018)

Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial
por: Heidegger, Isabel, et al.
Publicado: (2018)

Budget Impact of Enzalutamide for Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
por: Bui, Cat N., et al.
Publicado: (2016)

Comment on: Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis by Jing Li et al.
por: Wilkinson, Scott, et al.
Publicado: (2022)

Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers
por: Odri, Guillaume Anthony, et al.
Publicado: (2022)

Oncogenic drivers and mitochondrial dependency
por: Alvarez-Calderon, Francesca, et al.
Publicado: (2015)

DNA methylation-based profiling of horse archaeological remains for age-at-death and castration
por: Liu, Xuexue, et al.
Publicado: (2023)

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer
por: Hennigan, S. Thomas, et al.
Publicado: (2019)

Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)
por: Li, Yan, et al.
Publicado: (2022)

Phosphorylation of the androgen receptor at Ser81 is co‐sustained by CDK1 and CDK9 and leads to AR‐mediated transactivation in prostate cancer
por: Gao, XinTao, et al.
Publicado: (2021)

Oncogenic driver mutations in lung cancer
por: Luo, Susan Y, et al.
Publicado: (2013)

The development of a post-mortem interval estimation for human remains found on land in the Netherlands
por: Gelderman, H. T., et al.
Publicado: (2017)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer
por: Francini, Edoardo, et al.
Publicado: (2021)

Metastatic prostate cancer remains incurable, why?
por: Dong, Liang, et al.
Publicado: (2019)

The long tail of oncogenic drivers in prostate cancer
por: Armenia, Joshua, et al.
Publicado: (2018)

Oncogenic Viruses as Entropic Drivers of Cancer Evolution
por: Tempera, Italo, et al.
Publicado: (2021)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
por: Sugawara, Tatsuo, et al.
Publicado: (2016)

"I found that I was well and strong": Women’s motivations for remaining on ART under Option B+ in Malawi
por: Phiri, Nozgechi, et al.
Publicado: (2018)

PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer
por: Sha, Jianjun, et al.
Publicado: (2016)

Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration
por: Zaitsu, Masayoshi, et al.
Publicado: (2012)

Predicting the effects of multiple global change drivers on microbial communities remains challenging
por: Suleiman, Marcel, et al.
Publicado: (2022)

High incidence of oncogenic HPV genotypes found in women from Southern Brazil
por: Entiauspe, Ludmila G, et al.
Publicado: (2014)

Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels
por: Magari, Tomohiro, et al.
Publicado: (2014)

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
por: Naramura, Mayumi, et al.
Publicado: (2011)

Targeting MET Amplification as a New Oncogenic Driver
por: Kawakami, Hisato, et al.
Publicado: (2014)

Bcl-x(L) is an oncogenic driver in colorectal cancer
por: Scherr, Anna-Lena, et al.
Publicado: (2016)

Ribosomal proteins: a novel class of oncogenic drivers
por: Sulima, Sergey O., et al.
Publicado: (2017)

Concomitant Pathogenic Mutations and Fusions of Driver Oncogenes in Tumors
por: Zhang, Runjiao, et al.
Publicado: (2021)

Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014)

Treatment sequencing in metastatic castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)

Abiraterone in the treatment of metastatic castration-resistant prostate cancer
por: Mostaghel, Elahe A
Publicado: (2014)

Enzalutamide for patients with metastatic castration-resistant prostate cancer
por: Ramadan, Wijdan H, et al.
Publicado: (2015)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2015)

PSMA theragnostics for metastatic castration resistant prostate cancer
por: Song, Hong, et al.
Publicado: (2022)

Identification of World War II bone remains found in Ukraine using classical anthropological and mitochondrial DNA results
por: Dudás, Eszter, et al.
Publicado: (2019)

Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials
por: Kharlamov, Alexander N
Publicado: (2018)

Metastatic Renal Cell Carcinoma Found in the Stomach and Duodenum
por: Mehta, Neal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dbaeakv6dotlvjpeq8ds4p3vqp